Breakthrough blood pressure pill enters final testing phase
NCT ID NCT07030101
Summary
This study is testing whether a new medication called TCA108 can help lower blood pressure in adults whose high blood pressure isn't well controlled with their current medications. Researchers will enroll 400 adults who still have high blood pressure despite taking two different blood pressure drugs. Participants will take either the new medication or a placebo (dummy pill) for 10 weeks while researchers measure changes in their blood pressure and monitor for side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.